Stevanato Group S.p.A. (NYSE:STVN) Receives Average Recommendation of "Moderate Buy" from Brokerages

Key Points

• "Moderate Buy" consensus from six analysts, comprising 1 sell, 1 hold, 3 buy and 1 strong-buy rating, according to MarketBeat.
• Major brokers have trimmed price targets (e.g., Citigroup to $26, Morgan Stanley to $19, KeyCorp to $32, Jefferies $17.50), while the stock opened at €13.70 and is trading below its 50‑day (€15.09) and 200‑day (€20.03) moving averages.
• Stevanato reported quarterly EPS of €0.18 on €346.5M revenue, with a market cap of about $4.15B and a P/E of 23.6; analysts forecast roughly 0.5 EPS for the current year.

Shares of Stevanato Group S.p.A. (NYSE:STVN - Get Free Report) have received a consensus rating of "Moderate Buy" from the six analysts that are presently covering the firm, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating, three have assigned a buy rating and one has issued a strong buy rating on the company.

Several equities research analysts have issued reports on STVN shares. Jefferies Financial Group set a $17.50 price target on Stevanato Group in a report on Tuesday, February 10th. Citigroup lowered their price target on Stevanato Group from $32.00 to $26.00 and set a "buy" rating for the company in a report on Thursday, March 5th. Morgan Stanley lowered their price target on Stevanato Group from $24.00 to $19.00 and set an "equal weight" rating for the company in a report on Friday, March 6th. KeyCorp lowered their price target on Stevanato Group from $37.00 to $32.00 and set an "overweight" rating for the company in a report on Thursday, March 5th. Finally, Wall Street Zen downgraded Stevanato Group from a "buy" rating to a "hold" rating in a report on Saturday, February 14th.

Stevanato Group Trading Down 0.7%

NYSE STVN opened at €13.70 on Thursday. The stock has a 50-day simple moving average of €15.09 and a 200 day simple moving average of €20.03. The company has a market capitalization of $4.15 billion, a PE ratio of 23.62, a P/E/G ratio of 1.23 and a beta of 0.62. The company has a current ratio of 1.76, a quick ratio of 1.26 and a debt-to-equity ratio of 0.23. Stevanato Group has a 12 month low of €12.89 and a 12 month high of €28.00.

Stevanato Group (NYSE:STVN - Get Free Report) last released its quarterly earnings data on Saturday, February 14th. The company reported €0.18 EPS for the quarter. The business had revenue of €346.50 million during the quarter. Stevanato Group had a return on equity of 10.44% and a net margin of 11.83%. Research analysts forecast that Stevanato Group will post 0.5 EPS for the current year.

Institutional Investors Weigh In On Stevanato Group

Large investors have recently modified their holdings of the business. Farther Finance Advisors LLC bought a new stake in shares of Stevanato Group in the third quarter worth about $44,000. First Horizon Corp bought a new stake in shares of Stevanato Group in the third quarter worth about $50,000. State of Wyoming increased its holdings in shares of Stevanato Group by 39,216.7% in the second quarter. State of Wyoming now owns 2,359 shares of the company's stock worth $58,000 after acquiring an additional 2,353 shares in the last quarter. GW&K Investment Management LLC increased its holdings in shares of Stevanato Group by 76.2% in the fourth quarter. GW&K Investment Management LLC now owns 2,440 shares of the company's stock worth $49,000 after acquiring an additional 1,055 shares in the last quarter. Finally, Quantbot Technologies LP acquired a new position in shares of Stevanato Group during the third quarter worth about $68,000.

Stevanato Group Company Profile

Stevanato Group is a global provider of primary packaging solutions and related services for the pharmaceutical and biotech industries. The company specializes in the design, development and manufacturing of glass drug containers such as vials, cartridges and pre-fillable syringes, as well as advanced inspection systems and assembly equipment. Its integrated offerings cover the entire packaging supply chain, from component production to bespoke filling lines and serialization technology.

In addition to its core glass business, Stevanato Group delivers engineering services and process validation support to pharmaceutical customers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.